Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Systems
Depression

About this trial
This is an interventional treatment trial for Depression focused on measuring Mobile Technologies
Eligibility Criteria
Inclusion Criteria:
Participants will be screened by phone. Inclusion criteria:
Participants must:
- be between the ages of 18 and 65,
- report current elevated depressive symptoms, and
- currently own an iOS-compatible mobile phone.
Exclusion Criteria:
Participants will be excluded if they:
- are currently receiving psychotherapy or psychotropic medication,
- plan to seek psychotherapy within the next 3 months (score > 5 on a self-report 1-10 scale of likelihood to seek treatment),
endorse current suicidal ideation defined as either
- a response of "I would like to kill myself" or "I would kill myself if I had the chance" on the suicidal thoughts or wishes item of the BDI-II or
- an indication of past month suicidal ideation on the MDD module of the SCID-IV (see Protection of Human Subjects for additional details), or
- meet current diagnostic criteria for MDD; although BA has been used to treat MDD, Moodivate is targeted specifically to elevated symptoms, not major depressive episodes.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
Behavioral Activation
Cognitive Based Therapy
Treatment as Usual
Behavioral Activation will be administered via Moodivate will mirror the core BA components outlined above. Moodivate will also be modified for a mobile environment in key ways, with the most salient being: 1) Elimination of the need for a therapist: By eliminating the need for a therapist, we will be able to reach a broad patient/consumer base that may not utilize traditional therapy resources and will combat the primary barrier to PCPs recommending psychotherapy to their patients with elevated depressive symptoms and 2) Elimination of paper forms: By eliminating paper forms, we will increase the sensitivity of BA to motivational and organizational deficits frequently observed in patients with elevated depressive symptoms while also increasing treatment fidelity by prompting the patient to complete activities at scheduled times and giving the patient reinforcement for completing activities.
Moodkit will be used to administer cognitive based therapy which is commonly compared to behavioral activation.
TAU will be provided to individuals. These subject will be provided with therapy but will not utilize a mobile application.